Πάρκινσον Φάρος
For health professionals
The Impact of gut microbiota on Parkinson’s disease
An international meta-analysis reveals significant alterations in the gut microbiota and metabolic pathways in individuals with Parkinson’s disease, with indications of a potential link between biotin and riboflavin deficiencies and disease progression
GT-02287: A promising GCase-targeted therapy for Parkinson’s disease by Gain therapeutics
Gain Therapeutics’ GT-02287 is designed to enhance GCase function as a disease-modifying strategy for Parkinson’s disease, showing encouraging results in preclinical studies
The effect of anxiety on gait in Parkinson’s disease: Insights from motion sensor analysis
This study investigates how anxiety influences gait parameters in people with Parkinson’s disease, highlighting the importance of recognizing and managing anxiety to improve mobility and treatment outcomes
Recommendations for managing gastrointestinal dysfunction in Parkinson’s disease
A clinical guide outlining the most effective strategies for managing gastrointestinal issues in patients with Parkinson’s disease
Cutting-edge developments in Parkinson’s disease therapies
Emerging approaches and innovative interventions that are shaping the future of Parkinson’s disease treatment
Latest clinical trials in Parkinson’s disease
What healthcare professionals need to know about current clinical trials in Parkinson’s disease